LocanaBio IPO

locanabio.com

Locanabio develops a new class of genetic medicines that deliver RNA binding protein-based systems to correct the message of disease-causing RNA.

Founded2016
Total Funding to Date$159MM
Register for Details

For more details on financing and valuation for LocanaBio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

LocanaBio Ticker Symbol

LocanaBio does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

LocanaBio Stock Price

The stock price for LocanaBio will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

LocanaBio Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
12/14/2020 Series B $317.84MM $XXX.XX $XXX.XX
5/22/2019 Series A $79.28MM $XXX.XX $XXX.XX
10/31/2017 Series Seed $8MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like LocanaBio in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM